| Resectability by three-dimensional visualization evaluation | |||
---|---|---|---|---|
Clinicopathological features | Total | Resectable group | Unresectable group | P value |
No. of patients | 111 | 80 | 31 | Â |
Age (years)a | 65 ± 10 | 66 ± 9 | 62 ± 11 | 0.053 |
Sex (M/F) | 68/43 | 51/29 | 17/14 | 0.387 |
Preoperative biliary drainage | 20/91 | 17/63 | 3/28 | 0.155 |
Tumor size(≤ 1/1 ~ 3 cm/ ≥ 3 cm | 8/45/58 | 6/35/39 | 2/10/19 | 0.488 |
Tumor form | Â | Â | Â | 0.016 |
 Sclerosing | 43 | 35 | 8 |  |
 Mass | 50 | 32 | 18 |  |
 Polypoid | 9 | 9 | 0 |  |
 Mixed | 9 | 4 | 5 |  |
Tumor differentiation (well/moderately/poorly) | 3/80/28 | 2/59/19 | 1/21/9 | 0.818 |
Hepatic artery involvementb | 57(52.3%) | 34(42.5%) | 23(79.3%) |  < 0.001 |
Portal vein involvementc | 55(50.0%) | 31(38.6%) | 24(80.0%) |  < 0.001 |
Hepatic vein involvement | 5(4.5%) | 3(3.8%) | 2(6.5%) | 0.538 |
Lymph node metastasisd | 54(49.1%) | 31(38.8%) | 23(76.7%) |  < 0.001 |
Distant metastasis | 5(4.5%) | 1(1.3%) | 4(12.9%) | 0.008 |
Perineural invasion | 56(50.5%) | 35(43.8%) | 21(67.7%) | 0.023 |
Hepatic lobe atrophy | 21(18.9%) | 10(12.5%) | 11(35.5%) | 0.006 |
Resection status |  |  |  |  < 0.001 |
 R0 | 71(64.9%) | 63(78.8%) | 8(25.8%) |  |
 R1 | 15(13.5%) | 15(18.8%) | 0(0.0%) |  |
 R2 | 7(6.3%) | 1(1.2%) | 6(19.4%) |  |
 Unresectable | 18(16.2%) | 1(1.2%) | 17(54.8%) |  |